Valsartan Lawsuit Lawyers in Indianapolis

Legal support for Those with Cancer Caused by High Blood Pressure & Heart
Failure Drugs

The U.S. Food and Drug Administration (FDA) announced a voluntary recall
of several generic drugs containing active ingredient valsartan in July
2018. Valsartan could increase the risk of certain types of cancers and
create other adverse health effects such as long-term liver damage. The
ingredient found in batches of drugs most commonly used to treat hypertension,
recent heart attacks and people in heart failure, could be tainted by
a probable human carcinogen, N-nitrosodimethylamine (NDMA) and dangerous
to anyone who takes the medication.

“We have carefully assessed the valsartan-containing medications sold in
the United States, and we’ve found that the valsartan sold by these
specific companies does not meet our safety standards. This is why we’ve
asked these companies to take immediate action to protect patients,” said in an FDA Safety Announcement by Dr. Janet Woodcock, director
of Center for Drug Evaluation and Research at the FDA.

Wagner Reese, LLP’s Indianapolis defective drug lawyers are currently representing
clients sickened or injured by generic drugs containing valsartan and
are available to speak with others who were prescribed a valsartan medication
and have since been diagnosed with liver damage, tumors, or cancers.

Jason Reese Discusses Valsartan Recall

Not All Drug Makers Have Joined the FDA Valsartan Recall

Three U.S. companies that sell the generic drug have joined the recall
effort. Patients should know that not all drugs containing valsartan were
named in the official FDA voluntary recall. The current list of drugs
containing valsartan is expected to be expanded as more
defective medications may be added.

22 other countries had previously recalled valsartan containing products
used to treat serious conditions like high blood pressure and heart failure.
Use of drugs with tainted valsartan is widespread making the U.S. recall
slow and difficult. While some U.S. pharmaceutical companies are communicating
with distributors and customers by letter and email to arrange for return
of all recalled products, it remains doubtful all persons will be reached
before being impacted.

Cardiac Medicines Tainted with Dangerous Carcinogen

FDA investigators found that medications containing valsartan supplied
by the Chinese company, Zhejiang Huahai Pharmaceuticals may have been
exposed to N-nitrosodimethylamine’s (NDMA) carcinogenic and toxic
impurities since 2012. They have been supplying these dangerous drugs
to U.S. pharmaceutical companies for processing and distribution in the
US market through July 2018. According to the Environmental Protection
Agency (EPA), NDMA is a semi-volatile organic chemical that forms in both
industrial and natural processes. The B2 (probable human) carcinogen should
not be found within an active ingredient in a patient’s life-saving
medication.

NDMA is not currently produced in pure form or commercially used in the
United States, except for research purposes.

It was formerly used in the production of liquid rocket fuel, antioxidants,
additives for lubricants and softeners for copolymers.

NDMA can also be found naturally, in trace amounts in certain foods. NDMA
is released in these foods through chemical reactions during the food
preparation process. For example, NDMA can be produced by grilling, browning,
and salting of certain meats.

NDMA can be unintentionally produced in and released from industrial sources
through chemical reactions, such as those that involve alkylamines.

Valsartan Medication & Known Patient Warnings

Valsartan is an active ingredient found in a number of generic drugs most
commonly used to treat hypertension, heart failure, left ventricular failure,
and left ventricular dysfunction following myocardial infarction. The
drugs are believed to be putting consumers at risk of developing a number
of life-threatening cancers because of the NDMA universal carcinogen exposure
with the potential to cause sickness to almost all human organs.

Studies have specifically shown NDMA to induce tumors to form in the liver,
kidney, and respiratory tract resulting in:

Liver cancer

Gastric cancer

Colorectal cancer

Kidney cancer

Lung cancer

NMDA exposure has also been associated with non-cancerous liver damage,
according to the US Department of Health and Human Services. The high
level short-term and low level, long-term exposures of NMDA which cause
liver issues can result in internal bleeding and death if left untreated.

Prescribing Physicians Should Be Alerted

FDA drug safety officials have alerted health care systems and medical
professionals of the tainted drugs but say patients should not stop taking
the recalled products without first contacting their treating physicians.
Health professionals will need to prescribe a replacement drug.

According to FDA warnings, patients who show signs of the following medical
issues are especially at risk:

Hereditary angioedema

Volume depletion

Severe congestive heart failure (CHF)

Hyperkalemia

Hepatic or renal impairment

Aortic stenosis

Mitral valve stenosis

Pregnant women should talk to their doctor about taking generic drugs containing
valsartan as the carcinogen laced ingredient can result in fetal toxicity,
and cause
injury and
death to the developing fetus or newborn.

Filing a Valsartan Lawsuit & Personal Injury Claim

Wagner Reese is already representing a victim of a valsartan related injury
and can help file a claim for you or your loved one as well. If you were
taking any of the contaminated valsartan medications, and have experienced
liver damage, tumor, cancer or other alarming health issues, our job is
to seek damages for you including but not limited to:

Past and future medical expenses to treat your injuries

Past and future pain and suffering that results from your injuries, both
physical and emotional

Wage loss

Financial losses experienced because of your injuries

Punitive damages

Wagner Reese has an experienced team of
product liability and medical malpractice attorneys in Indianapolis who will continue to
investigate claims against manufacturers and distributors of the medications
containing the active ingredient Valsartan in hopes to help consumers
at risk of developing a number of life-threatening cancers or related
health injuries.

Have You Been Seriously Injured by a Defective or Dangerous Medicine Containing
Valsartan?

Defective medication or health product cases are complex and often leave
consumers in a vulnerable place. Whether your medicine-related injuries
were caused by defectively designed or manufactured drugs, by hidden side-effects,
or by inadequate warnings by drug sales representatives or medical professionals,
we offer a free, no-obligation consultation to help you.

Our experienced defective drug attorneys can provide you the legal support
and advice you need so that you can focus on your own health and healing.

Simply give us a call today at (888) 204-8440 to schedule a free consultation
or speak with us by submitting our
online form and our attorneys will review your information regarding your Valsartan
concerns. By filling out the contact form, you agree to receive telephone
calls and text messages at the telephone number provided above (including
any mobile number provided) from Wagner Reese and their third-party companies.

Note: While at this time we are not filing claims related to a Valsartan
lawsuit, we are happy to retain your information during our investigation.
If we are able to move forward with a lawsuit, we will contact you.

Valsartan FDA Recall Video Transcript

In July 2018, the FDA recalled a widely used medication called Valsartan
amid concerns that it was contaminated with a cancer-causing chemical
called NDMA. Valsartan is used to treat high blood pressure and heart
failure. Twenty-two countries previously recalled the drug. Valsartan
is the generic version of a drug called Diovan. Many versions of Valsartan
containing medications were recalled from several different manufacturers.

Attorneys at Wagner Reese, LLP are exploring mass tort litigation against
the manufacturers and distributors of Valsartan. We have compiled some
questions we’ve heard frequently from those who may have been affected
by the recent recall. One of the most common questions we have heard is
what medications are included in the recall? It’s important to understand
that not all Valsartan containing medications have been recalled, only
Valsartan medication manufactured by certain companies have been included,
including those from Teva Pharmaceutical, Major Pharmaceuticals, Soleco
Healthcare, and others. The recall continues to be expanded as the FDA
investigates. You can find a full list of recalled medication on the FDA
website. Visit www.FDA.gov.

Another question we hear frequently is from those who took Valsartan wondering
what should they do. We recommend contacting your pharmacist to learn
if your medication has been part of the recall. You should ask your pharmacist
whether any of the blood pressure medications you have taken since 2012
may have been included in the recall.

Another question we see is after those have confirmed that their medication
was part of the recall, what should they do next. Do not stop taking your
medication. Consult your prescribing doctor to discuss your options. Abruptly
stopping Valsartan without a replacement could cause serious harm. We
also recommend keeping prescription bottles and any recall notices, and
of course, contact Wagner Reese for a free consultation.

Another question we hear is from those who have been diagnosed with cancer
wondering could their cancer diagnosis have been due to Valsartan medication.
Research shows a 1 in 8,000 chance of getting cancer about being exposed
to the excessive levels of carcinogens in some Valsartan medications.
Although this may not seem like a lot, this is a significant and potentially
deadly risk to many thousands of patients. Toxicologists are still investigating
the types of cancer that may be caused by the chemical contaminant NDMA,
which could include cancers of the liver, kidney, stomach, colon, esophagus,
respiratory tract, mouth, and others.

Another question we hear is those wondering whether there are other harmful
effects caused by NDMA. Liver and kidney damage are being reported across
the country. Consult your primary care physician to obtain appropriate
testing if you have concerns regarding your liver or kidney function after
taking Valsartan medications.

Does it matter how long an individual was taking Valsartan? The answer
is yes. We believe that patients taking recalled Valsartan longer than
30 days warrant investigation. Patients taking Valsartan from 2012 to
the present may have the strongest possibility of receiving the contaminated
medication.

If you or a loved one may have been harmed by recalled Valsartan medication,
contact the aggressive trial lawyers at Wagner Reese, LLP at the phone
number listed on your screen. There is no fee if no recovery is made on
your behalf.

Meet Our TEAM

Our attorneys have more than nine decades of collective legal experience
and have been honored, both by their peers and by a number of prestigious
legal organizations, for their commitment to quality legal services and
the highest level of ethics. Most of all, our attorneys understand that,
for you, this isn’t just another case. It’s your life. Because of this,
we are dedicated to providing compassionate, personalized legal services
tailored to your unique needs. We take your specific situation into account
and work to provide custom legal solutions that suit your particular goals.

The information on this website is for general information purposes only.
Nothing on this site should be taken as legal advice for any individual
case or situation. This information is not intended to create, and receipt
or viewing does not constitute, an attorney-client relationship.

x

⚠

Your browser is out of date. To get the full experience of this website,
please update to most recent version.